Core Insights - Southbound funds increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 3.83 million shares on October 16, 2025, marking a 0.27% increase in total holdings [1] - Over the past five trading days, there have been three days of net increases, totaling 11.73 million shares, while in the last twenty trading days, there were fifteen days of net increases, amounting to 75.63 million shares [1] - As of now, southbound funds hold 1.439 billion shares of Jinxin Reproductive Medicine, representing 52.15% of the company's total issued ordinary shares [1] Summary by Category Trading Activity - On October 16, 2025, total shares held reached 1.439 billion, with an increase of 3.83 million shares [2] - On October 15, 2025, the total shares held were 1.435 billion, with an increase of 11.23 million shares [2] - On October 14, 2025, total shares held were 1.424 billion, with an increase of 5.13 million shares [2] - On October 13, 2025, total shares held were 1.418 billion, with a decrease of 0.94 million shares [2] - On October 3, 2025, total shares held were 1.419 billion, with a decrease of 7.52 million shares [2] Company Overview - Jinxin Reproductive Medicine is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, obstetrics and pediatrics medical services, and engages in the sale of medical consumables and equipment [2] - Jinxin Reproductive Medicine operates mainly in China and the United States [2]
锦欣生殖（01951.HK）：10月16日南向资金增持383.35万股